FILSUVEZ

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Romania, United Kingdom

Active ingredients

The drug FILSUVEZ contains one active pharmaceutical ingredient (API):

1 Betulin UNII 6W70HN7X7O - BETULIN

Betulin accelerated re-epithelialization in an in vitro wound scratch assay using human primary keratinocytes at the dosage of 1 μg/ml, and in a porcine ex vivo wound healing model at the dosage of 10 µg/ml. The precise mechanism of action of the active substance in wound healing in humans is not known. Read about Betulin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FILSUVEZ Gel	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D03AX13		D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03A Cicatrizants → D03AX Other cicatrizants
Discover more medicines within D03AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 3049196, 3049208, 3049219, 3049220, 3049231
Country: FR	Base de données publique des médicaments	Identifier(s): 60528073
Country: IT	Agenzia del Farmaco	Identifier(s): 050219017, 050219029, 050219031, 050219043, 050219056
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1095021, 1095022
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69224001, W69224002